{"transactions":[{"id":961747,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":71074,"kind":"person","name":"Chivukula Pad","position":1,"cik":"0001727317","reported_name":"Chivukula Pad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer & COO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-12-19T17:21:54.000Z","date":"2025-12-17","kind":"grant","planned":false,"acquired":true,"shares":54000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents options to purchase shares of common stock granted pursuant to the Company's Amended and Restated 2019 Omnibus Equity Incentive Plan, as amended."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying this option vest 25% on December 17, 2026, the first anniversary of the date of grant, and the remainder vest in equal increments on each successive one-month anniversary thereafter for the next thirty-six months."}],"balance_after":54000,"derivative":{"exercise_price":6.52,"expiration_date":"2035-12-17","underlying":"Common Stock","underlying_shares":54000},"source":{"system":"sec-edgar","filing":"0001193805-25-001766","document":"e665060_4-chivukula.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1727317/000119380525001766/e665060_4-chivukula.xml","form_type":"4"}},{"id":1326125,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":71074,"kind":"person","name":"Chivukula Pad","position":1,"cik":"0001727317","reported_name":"Chivukula Pad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer & COO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-12-18T16:06:26.000Z","date":"2024-12-16","kind":"grant","planned":false,"acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents options to purchase shares of common stock granted pursuant to the Company's Amended and Restated 2019 Omnibus Equity Incentive Plan, as amended."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying this option vest 25% on December 16, 2025, the first anniversary of the date of grant, and the remainder vest in equal increments on each successive one-month anniversary thereafter for the next thirty-six months."}],"balance_after":60000,"derivative":{"exercise_price":16.24,"expiration_date":"2034-12-16","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001193805-24-001491","document":"e664084_4-chivukula.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1727317/000119380524001491/e664084_4-chivukula.xml","form_type":"4"}},{"id":1385656,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":71074,"kind":"person","name":"Chivukula Pad","position":1,"cik":"0001727317","reported_name":"Chivukula Pad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer & COO"}}],"security":"Common Stock","published_at":"2024-10-16T21:05:50.000Z","date":"2024-10-15","kind":"sale","planned":true,"acquired":false,"shares":12000,"price":20.7601,"value":249121.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the weighted average price of 12,000 shares of common stock of Arcturus Therapeutics Holdings Inc. sold by the Reporting Person in multiple transactions on October 15, 2024, with sale prices ranging from $20.03 to $21.12 per share. The Reporting Person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":435334,"source":{"system":"sec-edgar","filing":"0001193805-24-001248","document":"e663956_4-chivukula.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1727317/000119380524001248/e663956_4-chivukula.xml","form_type":"4"}},{"id":1486046,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":71074,"kind":"person","name":"Chivukula Pad","position":1,"cik":"0001727317","reported_name":"Chivukula Pad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer & COO"}}],"security":"Common Stock","published_at":"2024-06-07T17:01:02.000Z","date":"2024-06-05","kind":"sale","planned":true,"acquired":false,"shares":114,"price":45,"value":5130.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the price of 114 shares of common stock of Arcturus Therapeutics Holdings Inc. sold by the Reporting Person on June 5, 2024. The Reporting Person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":447334,"source":{"system":"sec-edgar","filing":"0001193805-24-000768","document":"e663692_4-chivukula.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1727317/000119380524000768/e663692_4-chivukula.xml","form_type":"4"}},{"id":1491314,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":71074,"kind":"person","name":"Chivukula Pad","position":1,"cik":"0001727317","reported_name":"Chivukula Pad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer & COO"}}],"security":"Common Stock","published_at":"2024-06-04T16:05:45.000Z","date":"2024-06-03","kind":"sale","planned":true,"acquired":false,"shares":26000,"price":40.009,"value":1040234.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the weighted average price of 26,000 shares of common stock of Arcturus Therapeutics Holdings Inc. sold by the Reporting Person in multiple transactions on June 3, 2024, with sale prices ranging from $40.00 to $40.325 per share. The Reporting Person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":447448,"source":{"system":"sec-edgar","filing":"0001193805-24-000746","document":"e663681_4-chivukula.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1727317/000119380524000746/e663681_4-chivukula.xml","form_type":"4"}},{"id":1559163,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":71074,"kind":"person","name":"Chivukula Pad","position":1,"cik":"0001727317","reported_name":"Chivukula Pad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer & COO"}}],"security":"Common Stock","published_at":"2024-03-27T16:15:32.000Z","date":"2024-03-25","kind":"sale","planned":true,"acquired":false,"shares":17435,"price":35.02,"value":610573.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the weighted average price of 17,435 shares of common stock of Arcturus Therapeutics Holdings Inc. sold by the Reporting Person in multiple transactions on March 25, 2024, with sale prices ranging from $35.00 to $35.045 per share. The Reporting Person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":473448,"source":{"system":"sec-edgar","filing":"0001193805-24-000452","document":"e663461_4-chivukula.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1727317/000119380524000452/e663461_4-chivukula.xml","form_type":"4"}},{"id":1564515,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":71074,"kind":"person","name":"Chivukula Pad","position":1,"cik":"0001727317","reported_name":"Chivukula Pad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer & COO"}}],"security":"Common Stock","published_at":"2024-03-21T17:27:19.000Z","date":"2024-03-19","kind":"sale","planned":true,"acquired":false,"shares":8565,"price":35.0075,"value":299839.2375,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the weighted average price of 8,565 shares of common stock of Arcturus Therapeutics Holdings Inc. sold by the Reporting Person in multiple transactions on March 19, 2024, with sale prices ranging from $35.00 to $35.02 per share. The Reporting Person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":490883,"source":{"system":"sec-edgar","filing":"0001193805-24-000426","document":"e619136_4-chivukula.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1727317/000119380524000426/e619136_4-chivukula.xml","form_type":"4"}},{"id":1704133,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":71074,"kind":"person","name":"Chivukula Pad","position":1,"cik":"0001727317","reported_name":"Chivukula Pad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer & COO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-12-19T20:01:24.000Z","date":"2023-12-15","kind":"grant","planned":false,"acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents options to purchase shares of common stock granted pursuant to the Company's Amended and Restated 2019 Omnibus Equity Incentive Plan, as amended."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying this option vest 25% on December 15, 2024, the first anniversary of the date of grant, and the remainder vest in equal increments on each successive one-month anniversary thereafter for the next thirty-six months."}],"balance_after":125000,"derivative":{"exercise_price":28.88,"expiration_date":"2033-12-15","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001193805-23-001629","document":"e619136_4-chivukula.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1727317/000119380523001629/e619136_4-chivukula.xml","form_type":"4"}},{"id":1749304,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":71074,"kind":"person","name":"Chivukula Pad","position":1,"cik":"0001727317","reported_name":"Chivukula Pad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer & COO"}}],"security":"Common Stock","published_at":"2023-11-03T16:30:25.000Z","date":"2023-11-01","kind":"sale","planned":true,"acquired":false,"shares":5000,"price":18.7203,"value":93601.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the weighted average price of 5,000 shares of common stock of Arcturus Therapeutics Holdings Inc. sold by the Reporting Person in multiple transactions on November 1, 2023, with sale prices ranging from $18.39 to $19.27 per share. The Reporting Person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":499448,"source":{"system":"sec-edgar","filing":"0001193805-23-001470","document":"e619041_4-chivukula.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1727317/000119380523001470/e619041_4-chivukula.xml","form_type":"4"}},{"id":1764861,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":71074,"kind":"person","name":"Chivukula Pad","position":1,"cik":"0001727317","reported_name":"Chivukula Pad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer & COO"}}],"security":"Common Stock","published_at":"2023-10-04T16:06:30.000Z","date":"2023-10-02","kind":"sale","planned":true,"acquired":false,"shares":5000,"price":25.6123,"value":128061.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the weighted average price of 5,000 shares of common stock of Arcturus Therapeutics Holdings Inc. sold by the Reporting Person in multiple transactions on October 2, 2023, with sale prices ranging from $25.29 to $26.32 per share. The Reporting Person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":504448,"source":{"system":"sec-edgar","filing":"0001193805-23-001361","document":"e618979_4-chivukula.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1727317/000119380523001361/e618979_4-chivukula.xml","form_type":"4"}},{"id":1788697,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":71074,"kind":"person","name":"Chivukula Pad","position":1,"cik":"0001727317","reported_name":"Chivukula Pad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer & COO"}}],"security":"Common Stock","published_at":"2023-09-05T16:05:21.000Z","date":"2023-09-01","kind":"sale","planned":true,"acquired":false,"shares":5000,"price":31.4527,"value":157263.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the weighted average price of 5,000 shares of common stock of Arcturus Therapeutics Holdings Inc. sold by the Reporting Person in multiple transactions on September 1, 2023, with sale prices ranging from $30.70 to $31.75 per share. The Reporting Person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":509448,"source":{"system":"sec-edgar","filing":"0001193805-23-001249","document":"e618918_4-chivukula.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1727317/000119380523001249/e618918_4-chivukula.xml","form_type":"4"}},{"id":1815784,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":71074,"kind":"person","name":"Chivukula Pad","position":1,"cik":"0001727317","reported_name":"Chivukula Pad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer & COO"}}],"security":"Common Stock","published_at":"2023-08-03T16:15:01.000Z","date":"2023-08-01","kind":"sale","planned":true,"acquired":false,"shares":5000,"price":34.91,"value":174550.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the weighted average price of 5,000 shares of common stock of Arcturus Therapeutics Holdings Inc. sold by the Reporting Person in multiple transactions on August 1, 2023, with sale prices ranging from $34.44 to $35.70 per share. The Reporting Person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":514448,"source":{"system":"sec-edgar","filing":"0001193805-23-001075","document":"e618822_4-chivukula.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1727317/000119380523001075/e618822_4-chivukula.xml","form_type":"4"}},{"id":1827565,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":71074,"kind":"person","name":"Chivukula Pad","position":1,"cik":"0001727317","reported_name":"Chivukula Pad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer & COO"}}],"security":"Common Stock","published_at":"2023-07-18T18:50:53.000Z","date":"2023-07-14","kind":"sale","planned":true,"acquired":false,"shares":25000,"price":35.01,"value":875250.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the weighted average price of 25,000 shares of common stock of Arcturus Therapeutics Holdings Inc. sold by the Reporting Person in multiple transactions on July 14, 2023, with sale prices ranging from $35.00 to $35.04 per share. The Reporting Person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":519448,"source":{"system":"sec-edgar","filing":"0001193805-23-001003","document":"e618783_4-chivukula.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1727317/000119380523001003/e618783_4-chivukula.xml","form_type":"4"}},{"id":1832624,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":71074,"kind":"person","name":"Chivukula Pad","position":1,"cik":"0001727317","reported_name":"Chivukula Pad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer & COO"}}],"security":"Common Stock","published_at":"2023-07-07T06:01:35.000Z","date":"2023-07-03","kind":"sale","planned":true,"acquired":false,"shares":5000,"price":28.75,"value":143750.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the weighted average price of 5,000 shares of common stock of Arcturus Therapeutics Holdings Inc. sold by the Reporting Person in multiple transactions on July 3, 2023, with sale prices ranging from $28.57 to $28.96 per share. The Reporting Person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":544448,"source":{"system":"sec-edgar","filing":"0001193805-23-000955","document":"e618766_4-chivukula.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1727317/000119380523000955/e618766_4-chivukula.xml","form_type":"4"}},{"id":1866017,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":71074,"kind":"person","name":"Chivukula Pad","position":1,"cik":"0001727317","reported_name":"Chivukula Pad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer & COO"}}],"security":"Common Stock","published_at":"2023-06-05T16:07:21.000Z","date":"2023-06-01","kind":"sale","planned":true,"acquired":false,"shares":5000,"price":27.16,"value":135800.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the weighted average price of 5,000 shares of common stock of Arcturus Therapeutics Holdings Inc. sold by the Reporting Person in multiple transactions on June 1, 2023, with sale prices ranging from $26.87 to $27.54 per share. The Reporting Person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":549448,"source":{"system":"sec-edgar","filing":"0001193805-23-000824","document":"e618686_4-chivukula.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1727317/000119380523000824/e618686_4-chivukula.xml","form_type":"4"}},{"id":1894644,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":71074,"kind":"person","name":"Chivukula Pad","position":1,"cik":"0001727317","reported_name":"Chivukula Pad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer & COO"}}],"security":"Common Stock","published_at":"2023-05-12T16:05:46.000Z","date":"2023-05-11","kind":"sale","planned":true,"acquired":false,"shares":7925,"price":30.24,"value":239652.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reflects the weighted average price of 7,925 shares of common stock of Arcturus Therapeutics Holdings Inc. sold by the Reporting Person in multiple transactions on May 11, 2023, with sale prices ranging from $30.035 to $30.48 per share. The Reporting Person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":554448,"source":{"system":"sec-edgar","filing":"0001193805-23-000719","document":"e618625_4-chivukula.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1727317/000119380523000719/e618625_4-chivukula.xml","form_type":"4"}},{"id":1894643,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":71074,"kind":"person","name":"Chivukula Pad","position":1,"cik":"0001727317","reported_name":"Chivukula Pad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer & COO"}}],"security":"Common Stock","published_at":"2023-05-12T16:05:46.000Z","date":"2023-05-10","kind":"sale","planned":true,"acquired":false,"shares":17075,"price":30,"value":512250.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the weighted average price of 17,075 shares of common stock of Arcturus Therapeutics Holdings Inc. sold by the Reporting Person in multiple transactions on May 10, 2023, with sale prices ranging from $30.00 to $30.06 per share. The Reporting Person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":562373,"source":{"system":"sec-edgar","filing":"0001193805-23-000719","document":"e618625_4-chivukula.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1727317/000119380523000719/e618625_4-chivukula.xml","form_type":"4"}},{"id":1905506,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":71074,"kind":"person","name":"Chivukula Pad","position":1,"cik":"0001727317","reported_name":"Chivukula Pad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer & COO"}}],"security":"Common Stock","published_at":"2023-05-03T16:08:44.000Z","date":"2023-05-01","kind":"sale","planned":true,"acquired":false,"shares":5000,"price":25.93,"value":129650.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the weighted average price of 5,000 shares of common stock of Arcturus Therapeutics Holdings Inc. sold by the Reporting Person in multiple transactions May 1, 2023 with sale prices ranging from $25.39 to $26.58 per share. The Reporting Person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":579448,"source":{"system":"sec-edgar","filing":"0001193805-23-000656","document":"e618570_4-chivukula.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1727317/000119380523000656/e618570_4-chivukula.xml","form_type":"4"}},{"id":1924508,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":71074,"kind":"person","name":"Chivukula Pad","position":1,"cik":"0001727317","reported_name":"Chivukula Pad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer & COO"}}],"security":"Common Stock","published_at":"2023-04-05T20:47:40.000Z","date":"2023-04-03","kind":"sale","planned":true,"acquired":false,"shares":5000,"price":25.38,"value":126900.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the weighted average price of 5,000 shares of common stock of Arcturus Therapeutics Holdings Inc. sold by the Reporting Person in multiple transactions April 3, 2023 with sale prices ranging from $23.56 to $26.12 per share. The Reporting Person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":584448,"source":{"system":"sec-edgar","filing":"0001193805-23-000516","document":"e618445_4-chivukula.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1727317/000119380523000516/e618445_4-chivukula.xml","form_type":"4"}},{"id":1962464,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":71074,"kind":"person","name":"Chivukula Pad","position":1,"cik":"0001727317","reported_name":"Chivukula Pad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer & COO"}}],"security":"Common Stock","published_at":"2023-03-08T21:34:54.000Z","date":"2023-03-06","kind":"sale","acquired":false,"shares":5000,"price":16.07,"value":80350.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the weighted average price of 5,000 shares of common stock of Arcturus Therapeutics Holdings Inc. sold by the Reporting Person in multiple transactions March 6, 2023 with sale prices ranging from $15.66 to $16.09 per share. The Reporting Person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":589448,"source":{"system":"sec-edgar","filing":"0001193805-23-000295","document":"e618338_4-chivukula.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1727317/000119380523000295/e618338_4-chivukula.xml","form_type":"4"}},{"id":2087416,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":71074,"kind":"person","name":"Chivukula Pad","position":1,"cik":"0001727317","reported_name":"Chivukula Pad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer & COO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-12-13T16:06:52.000Z","date":"2022-12-09","kind":"grant","acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents options to purchase shares of common stock approved by the Board of Directors on December 9, 2022 pursuant to the Company's Amended and Restated 2019 Omnibus Equity Incentive Plan, as amended."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying this option vest 25% on December 9, 2023, the first anniversary of the date this award was approved by the Board of Directors, and the remainder vest in equal increments on each successive one-month anniversary thereafter for the next thirty-six months."}],"balance_after":125000,"derivative":{"exercise_price":16.92,"expiration_date":"2032-12-09","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001193805-22-001714","document":"e618107_4-chivukula.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1727317/000119380522001714/e618107_4-chivukula.xml","form_type":"4"}},{"id":2222691,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":71074,"kind":"person","name":"Chivukula Pad","position":1,"cik":"0001727317","reported_name":"Chivukula Pad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer & COO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-06-23T16:17:09.000Z","date":"2022-06-21","kind":"grant","acquired":true,"shares":85000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents options to purchase shares of common stock conditionally approved by the Board of Directors on December 10, 2021, subject to approval of an amendment to the Company's Amended and Restated 2019 Omnibus Equity Incentive Plan by the Company's stockholders, which approval was obtained at the Company's 2022 Annual Meeting of Stockholders held on June 21, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying this option vest 25% on December 10, 2022, the first anniversary of the date this award was conditionally approved by the Board of Directors, and the remainder vest in equal increments on each successive one-month anniversary thereafter for the next thirty-six months."}],"balance_after":85000,"derivative":{"exercise_price":34.57,"expiration_date":"2031-12-10","underlying":"Common Stock","underlying_shares":85000},"source":{"system":"sec-edgar","filing":"0001193805-22-001002","document":"e621773_4-chivukula.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1727317/000119380522001002/e621773_4-chivukula.xml","form_type":"4"}},{"id":2440978,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":71074,"kind":"person","name":"Chivukula Pad","position":1,"cik":"0001727317","reported_name":"Chivukula Pad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer & COO"}}],"security":"Common Stock","published_at":"2022-01-06T16:01:30.000Z","date":"2022-01-04","kind":"sale","acquired":false,"shares":8100,"price":40,"value":324000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":594448,"source":{"system":"sec-edgar","filing":"0001193805-22-000015","document":"e621194_4-chivukula.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1727317/000119380522000015/e621194_4-chivukula.xml","form_type":"4"}},{"id":2463494,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":71074,"kind":"person","name":"Chivukula Pad","position":1,"cik":"0001727317","reported_name":"Chivukula Pad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer & COO"}}],"security":"Common Stock","published_at":"2021-12-20T16:01:49.000Z","date":"2021-12-16","kind":"sale","acquired":false,"shares":3633,"price":40.0021,"value":145327.6293,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":602548,"source":{"system":"sec-edgar","filing":"0001193805-21-001784","document":"e621144_4-chivukula.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1727317/000119380521001784/e621144_4-chivukula.xml","form_type":"4"}},{"id":2476690,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":71074,"kind":"person","name":"Chivukula Pad","position":1,"cik":"0001727317","reported_name":"Chivukula Pad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer & COO"}}],"security":"Common Stock","published_at":"2021-12-10T16:01:29.000Z","date":"2021-12-08","kind":"sale","acquired":false,"shares":6367,"price":40,"value":254680.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":606181,"source":{"system":"sec-edgar","filing":"0001193805-21-001726","document":"e621144_4-chivukula.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1727317/000119380521001726/e621144_4-chivukula.xml","form_type":"4"}},{"id":2525577,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":71074,"kind":"person","name":"Chivukula Pad","position":1,"cik":"0001727317","reported_name":"Chivukula Pad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer & COO"}}],"security":"Common Stock","published_at":"2021-11-03T11:20:35.000Z","date":"2021-11-01","kind":"sale","acquired":false,"shares":10000,"price":44.41,"value":444100.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the weighted average price of 10,000 shares of common stock of Arcturus Therapeutics Holdings Inc. sold by the Reporting Person in multiple transactions on November 1, 2021 with sale prices ranging from $43.17 to $45.42 per share. The Reporting Person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":612548,"source":{"system":"sec-edgar","filing":"0001193805-21-001522","document":"e621049_4-chivukula.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1727317/000119380521001522/e621049_4-chivukula.xml","form_type":"4"}},{"id":2551185,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":71074,"kind":"person","name":"Chivukula Pad","position":1,"cik":"0001727317","reported_name":"Chivukula Pad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer & COO"}}],"security":"Common Stock","published_at":"2021-10-04T17:01:02.000Z","date":"2021-10-01","kind":"sale","acquired":false,"shares":10000,"price":44.36,"value":443600.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the weighted average price of 10,000 shares of common stock of Arcturus Therapeutics Holdings Inc. sold by the Reporting Person in multiple transactions on October 1, 2021 with sale prices ranging from $43.04 to $47.91 per share. The Reporting Person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":622548,"source":{"system":"sec-edgar","filing":"0001193805-21-001408","document":"e620990_4-chivukula.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1727317/000119380521001408/e620990_4-chivukula.xml","form_type":"4"}},{"id":2580934,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":71074,"kind":"person","name":"Chivukula Pad","position":1,"cik":"0001727317","reported_name":"Chivukula Pad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer & COO"}}],"security":"Common Stock","published_at":"2021-09-02T21:06:06.000Z","date":"2021-09-01","kind":"sale","acquired":false,"shares":10000,"price":55.86,"value":558600.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the weighted average price of 10,000 shares of common stock of Arcturus Therapeutics Holdings Inc. sold by the Reporting Person in multiple transactions on September 1, 2021 with sale prices ranging from $53.91 to $57.26 per share. The Reporting Person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":632548,"source":{"system":"sec-edgar","filing":"0001193805-21-001272","document":"e620921_4-chivukula.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1727317/000119380521001272/e620921_4-chivukula.xml","form_type":"4"}},{"id":2612463,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":71074,"kind":"person","name":"Chivukula Pad","position":1,"cik":"0001727317","reported_name":"Chivukula Pad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer & COO"}}],"security":"Common Stock","published_at":"2021-08-05T16:32:57.000Z","date":"2021-08-03","kind":"sale","acquired":false,"shares":10000,"price":40.07,"value":400700.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the weighted average price of 10,000 shares of common stock of Arcturus Therapeutics Holdings Inc. sold by the Reporting Person in multiple transactions on August 3, 2021 with sale prices ranging from $40.00 to $40.57 per share. The Reporting Person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":642548,"source":{"system":"sec-edgar","filing":"0001193805-21-001112","document":"e620845_4-chivukula.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1727317/000119380521001112/e620845_4-chivukula.xml","form_type":"4"}},{"id":2756567,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":71074,"kind":"person","name":"Chivukula Pad","position":1,"cik":"0001727317","reported_name":"Chivukula Pad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer & COO"}}],"security":"Common Stock","published_at":"2021-04-05T16:30:58.000Z","date":"2021-04-01","kind":"sale","acquired":false,"shares":10000,"price":42.95,"value":429500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the weighted average price of 10,000 shares of common stock of Arcturus Therapeutics Holdings Inc. sold by the Reporting Person in multiple transactions on April 1, 2021 with sale prices ranging from $41.55 to $44.26 per share. The Reporting Person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":652548,"source":{"system":"sec-edgar","filing":"0001193805-21-000455","document":"e620448_4-chivukula.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1727317/000119380521000455/e620448_4-chivukula.xml","form_type":"4"}},{"id":2810991,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":71074,"kind":"person","name":"Chivukula Pad","position":1,"cik":"0001727317","reported_name":"Chivukula Pad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer & COO"}}],"security":"Common Stock","published_at":"2021-03-03T16:30:42.000Z","date":"2021-03-01","kind":"sale","acquired":false,"shares":10000,"price":54.23,"value":542300.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the weighted average price of 10,000 shares of common stock of Arcturus Therapeutics Holdings Inc. sold by the Reporting Person in multiple transactions on March 1, 2021 with sale prices ranging from $53.34 to $55.36 per share. The Reporting Person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":662548,"source":{"system":"sec-edgar","filing":"0001193805-21-000323","document":"e620351_4-chivukula.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1727317/000119380521000323/e620351_4-chivukula.xml","form_type":"4"}},{"id":2880622,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":71074,"kind":"person","name":"Chivukula Pad","position":1,"cik":"0001727317","reported_name":"Chivukula Pad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer & COO"}}],"security":"Common Stock","published_at":"2021-02-03T16:45:33.000Z","date":"2021-02-01","kind":"sale","acquired":false,"shares":10000,"price":75.31,"value":753100.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the weighted average price of 10,000 shares of common stock of Arcturus Therapeutics Holdings Inc. sold by the Reporting Person in multiple transactions on February 1, 2021 with sale prices ranging from $73.19 to $76.60 per share. The Reporting Person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":672548,"source":{"system":"sec-edgar","filing":"0001193805-21-000124","document":"e620251_4-chivukula.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1727317/000119380521000124/e620251_4-chivukula.xml","form_type":"4"}},{"id":2918573,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":71074,"kind":"person","name":"Chivukula Pad","position":1,"cik":"0001727317","reported_name":"Chivukula Pad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer & COO"}}],"security":"Common Stock","published_at":"2021-01-05T18:19:56.000Z","date":"2021-01-04","kind":"sale","acquired":false,"shares":10000,"price":46.4,"value":464000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the weighted average price of 10,000 shares of common stock of Arcturus Therapeutics Holdings Inc. sold by the Reporting Person in multiple transactions on January 4, 2021 with sale prices ranging from $43.74 to $50.36 per share. The Reporting Person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":682548,"source":{"system":"sec-edgar","filing":"0001193805-21-000014","document":"e620192_4-chivukula.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1727317/000119380521000014/e620192_4-chivukula.xml","form_type":"4"}},{"id":2934087,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":71074,"kind":"person","name":"Chivukula Pad","position":1,"cik":"0001727317","reported_name":"Chivukula Pad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer & COO"}}],"security":"Stock Option (right to buy)","published_at":"2020-12-22T19:40:53.000Z","date":"2020-12-18","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares underlying the option vest on the one year anniversary of the date of grant, with the remainder vesting in 36 successive equal monthly increments thereafter."}],"balance_after":100000,"derivative":{"exercise_price":99.29,"expiration_date":"2030-12-18","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001193805-20-001610","document":"e620164_4-chivukula.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1727317/000119380520001610/e620164_4-chivukula.xml","form_type":"4"}},{"id":2957559,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":71074,"kind":"person","name":"Chivukula Pad","position":1,"cik":"0001727317","reported_name":"Chivukula Pad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer & COO"}}],"security":"Common Stock","published_at":"2020-12-03T17:45:56.000Z","date":"2020-12-01","kind":"sale","acquired":false,"shares":10000,"price":96.19,"value":961900.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects the weighted average price of 10,000 shares of common stock of Arcturus Therapeutics Holdings Inc. sold by the Reporting Person in multiple transactions on December 1, 2020 with sale prices ranging from $87.29 to $100.43 per share. The Reporting Person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":692548,"source":{"system":"sec-edgar","filing":"0001193805-20-001491","document":"e620114_4-chivukula.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1727317/000119380520001491/e620114_4-chivukula.xml","form_type":"4"}},{"id":2994090,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":71074,"kind":"person","name":"Chivukula Pad","position":1,"cik":"0001727317","reported_name":"Chivukula Pad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer & COO"}}],"security":"Common Stock","published_at":"2020-11-03T20:01:42.000Z","date":"2020-11-02","kind":"sale","acquired":false,"shares":10000,"price":55.28,"value":552800.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported price is the weighted average price per share sold by the reporting person. Reflects the weighted average price of 10,000 shares of common stock of Arcturus Therapeutics Holdings Inc. sold by the Reporting Person in multiple transactions on November 2, 2020 with sale prices ranging from $53.04 to $56.80 per share. The Reporting Person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":702548,"source":{"system":"sec-edgar","filing":"0000899243-20-030320","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1727317/000089924320030320/doc4.xml","form_type":"4"}},{"id":3015327,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":71074,"kind":"person","name":"Chivukula Pad","position":1,"cik":"0001727317","reported_name":"Chivukula Pad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer & COO"}}],"security":"Common Stock","published_at":"2020-10-02T17:00:09.000Z","date":"2020-10-01","kind":"sale","acquired":false,"shares":10000,"price":42.83,"value":428300.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported price is the weighted average price per share sold by the reporting person. Reflects the weighted average price of 10,000 shares of common stock of Arcturus Therapeutics Holdings Inc. sold by the Reporting Person in multiple transactions on October 1, 2020 with sale prices ranging from $41.57 to $44.04 per share. The Reporting Person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":712548,"source":{"system":"sec-edgar","filing":"0000899243-20-026884","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1727317/000089924320026884/doc4.xml","form_type":"4"}},{"id":3037224,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":71074,"kind":"person","name":"Chivukula Pad","position":1,"cik":"0001727317","reported_name":"Chivukula Pad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer & COO"}}],"security":"Common Stock","published_at":"2020-09-04T17:05:18.000Z","date":"2020-09-03","kind":"sale","acquired":false,"shares":10000,"price":45.16,"value":451600.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported price is the weighted average price per share sold by the reporting person after adjustment for a broker's error. Reflects the weighted average price of 10,000 shares of common stock of Arcturus Therapeutics Holdings Inc. sold by the Reporting Person in multiple transactions on September 3, 2020 with sale prices ranging from $42.60 to $47.93 per share. The Reporting Person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":722548,"source":{"system":"sec-edgar","filing":"0000899243-20-024363","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1727317/000089924320024363/doc4.xml","form_type":"4"}},{"id":3258692,"issuer":{"id":5523,"kind":"organization","name":"Arcturus Therapeutics Holdings Inc."},"owners":[{"id":71074,"kind":"person","name":"Chivukula Pad","position":1,"cik":"0001727317","reported_name":"Chivukula Pad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer & COO"}}],"security":"Stock Option (right to buy)","published_at":"2020-02-20T20:31:11.000Z","date":"2020-02-18","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares underlying the option vest on the one year anniversary of the date of grant, with the remainder vesting in 36 successive equal monthly increments thereafter."}],"balance_after":60000,"derivative":{"exercise_price":14.12,"expiration_date":"2030-02-18","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0000899243-20-005389","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1727317/000089924320005389/doc4.xml","form_type":"4"}},{"id":3665357,"issuer":{"id":160417,"kind":"organization","name":"Arcturus Therapeutics Ltd.","symbol":"ARCT"},"owners":[{"id":71074,"kind":"person","name":"Chivukula Pad","position":1,"cik":"0001727317","reported_name":"Chivukula Pad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer & COO"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2019-02-11T16:20:37.000Z","date":"2019-02-07","kind":"grant","acquired":true,"shares":38333,"price":4.99,"value":191281.67,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vesting over a period of four years from Vest Base Date, with 25% of the options vesting on the first anniversary thereof and the remainder vesting in equal monthly installments thereafter."}],"balance_after":38333,"derivative":{"exercise_price":4.99,"expiration_date":"2029-02-06","underlying":"Common Stock","underlying_shares":38333},"source":{"system":"sec-edgar","filing":"0001566049-19-000004","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1566049/000156604919000004/edgardoc.xml","form_type":"4"}},{"id":3665356,"issuer":{"id":160417,"kind":"organization","name":"Arcturus Therapeutics Ltd.","symbol":"ARCT"},"owners":[{"id":71074,"kind":"person","name":"Chivukula Pad","position":1,"cik":"0001727317","reported_name":"Chivukula Pad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer & COO"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2019-02-11T16:20:37.000Z","date":"2019-02-07","kind":"grant","acquired":true,"shares":1667,"price":4.99,"value":8318.33,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vesting over a period of four years from Vest Base Date, with 25% of the options vesting on the first anniversary thereof and the remainder vesting in equal monthly installments thereafter."}],"balance_after":1667,"derivative":{"exercise_price":4.99,"expiration_date":"2029-02-06","underlying":"Common Stock","underlying_shares":1667},"source":{"system":"sec-edgar","filing":"0001566049-19-000004","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1566049/000156604919000004/edgardoc.xml","form_type":"4"}}]}